Biodyne Co., Ltd. (314930.KQ)
KOSDAQ · KRW · Healthcare · Medical Instruments & Supplies
₩5,950 (-1.65%) as of
Key statistics
- Market cap
- 175.39B
- Forward P/E
- 25.54
- Dividend yield
- 0.00%
- 52-week range
- 5,500.00 – 16,860.00
- Beta
- 1.06
- Revenue (TTM)
- 5.77B
- Profit margin
- 21.18%
- Volume
- 26.32k
About Biodyne Co., Ltd.
Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea. The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis. It exports its products to Japan, Russia, Portugal, Thailand, and internationally. The company was founded in 1999 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Seoul, South Korea
- Employees
- 18
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.